Red Blood Cells as Smart Delivery Systems.

Red blood cells (RBCs), also called erythrocytes, are the most abundant type of blood cells. Recently, RBCs have been extensively studied as drug delivery systems because of their remarkable properties, including their inherent biocompatibility, low immunogenicity, flexibility, and long systemic circulation. Over the years, a number of different RBC-based drug delivery systems, including genetically engineered RBCs, nongenetically engineered RBCs, and RBC membrane-coated nanoparticles, have been explored, aiming at diverse biomedical applications. These techniques may address many challenging issues faced by traditional drug delivery systems, as demonstrated by the many successful preclinical results. Novel techniques dedicated to producing drug-carrying RBCs are currently undergoing the transition from preclinical research to the clinical realm. In this Topical Review, we will summarize the latest progress in the development of RBC-based smart delivery systems for various biomedical applications.

[1]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[2]  E. Beutler,et al.  Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Ronnie H. Fang,et al.  A biomimetic nanosponge that absorbs pore-forming toxins , 2013, Nature nanotechnology.

[4]  David S Lawrence,et al.  Red Blood Cells for Glucose‐Responsive Insulin Delivery , 2017, Advanced materials.

[5]  P. Poyet,et al.  Nanoerythrosome, a new derivative of erythrocyte ghost: preparation and antineoplastic potential as drug carrier for daunorubicin. , 1994, Anticancer research.

[6]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[7]  Harvey F Lodish,et al.  Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes , 2014, Proceedings of the National Academy of Sciences.

[8]  B. Bax,et al.  Preclinical toxicity evaluation of erythrocyte-encapsulated thymidine phosphorylase in BALB/c mice and beagle dogs: an enzyme-replacement therapy for mitochondrial neurogastrointestinal encephalomyopathy. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  Samir Mitragotri,et al.  Long Circulating Nanoparticles via Adhesion on Red Blood Cells: Mechanism and Extended Circulation , 2007, Experimental biology and medicine.

[10]  Laura Chiarantini,et al.  Erythrocytes deliver Tat to interferon‐γ‐treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro , 2002, Journal of leukocyte biology.

[11]  Liangfang Zhang,et al.  Engineering red‐blood‐cell‐membrane–coated nanoparticles for broad biomedical applications , 2015 .

[12]  Zhuang Liu,et al.  Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy. , 2017, Small.

[13]  T. Tsong,et al.  Electroporation of cell membranes. , 1991, Biophysical journal.

[14]  C. M. Williams,et al.  Methotrexate loaded erythrocyte carriers optimizing their formation their characterization and their pharmacological efficacy in treating hepatoma 129 ascites tumors in mice , 1987 .

[15]  Xiaoqi Sun,et al.  Multifunctional Theranostic Red Blood Cells For Magnetic‐Field‐Enhanced in vivo Combination Therapy of Cancer , 2014, Advanced materials.

[16]  Tza-Huei Wang,et al.  Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging. , 2017, ACS applied materials & interfaces.

[17]  M. Shin,et al.  Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor. , 1986, Journal of immunology.

[18]  M. Magnani,et al.  Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution. , 2016, Advanced drug delivery reviews.

[19]  Chao Wang,et al.  Erythrocyte‐Membrane‐Enveloped Perfluorocarbon as Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer Radiotherapy , 2017, Advanced materials.

[20]  Feng Gao,et al.  Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. , 2014, ACS nano.

[21]  D. Fearon,et al.  Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Pu Wang,et al.  Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer's disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice. , 2017, Biomaterials.

[23]  Zhiping Zhang,et al.  Cell or Cell Membrane-Based Drug Delivery Systems , 2015, Theranostics.

[24]  Takashi Miwa,et al.  Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. , 2002, Blood.

[25]  M. Cremonesi,et al.  Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity. , 1998, British Journal of Cancer.

[26]  M. Magnani,et al.  Reengineering red blood cells for cellular therapeutics and diagnostics. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[27]  Ronnie H. Fang,et al.  Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. , 2013, Nanoscale.

[28]  Liangzhu Feng,et al.  Photosensitizer Decorated Red Blood Cells as an Ultrasensitive Light-Responsive Drug Delivery System. , 2017, ACS applied materials & interfaces.

[29]  M. Magnani,et al.  Cell-based drug delivery. , 2008, Advanced drug delivery reviews.

[30]  Samir Mitragotri,et al.  Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems. , 2016, Advanced drug delivery reviews.

[31]  Laurent Kiger,et al.  Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells , 2005, Nature Biotechnology.

[32]  Helmuth Möhwald,et al.  Nanoplasmonics for dual-molecule release through nanopores in the membrane of red blood cells. , 2012, ACS nano.

[33]  Morgan L. Maeder,et al.  Genome-editing Technologies for Gene and Cell Therapy , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[35]  Ronnie H. Fang,et al.  Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. , 2014, Nanoscale.

[36]  Liangfang Zhang,et al.  Cell membrane-camouflaged nanoparticles for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[37]  H. Lodish,et al.  Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease , 2017, Proceedings of the National Academy of Sciences.

[38]  Ronnie H. Fang,et al.  Erythrocyte membrane‐coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[39]  Peng Yang,et al.  Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy. , 2017, Biomaterials.

[40]  Kemin Wang,et al.  Red blood cell membrane-mediated fusion of hydrophobic quantum dots with living cell membranes for cell imaging. , 2016, Journal of materials chemistry. B.

[41]  Ronnie H. Fang,et al.  'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. , 2013, Nanoscale.

[42]  D L Simmons,et al.  CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells , 1989, The Journal of experimental medicine.

[43]  Mehrdad Hamidi,et al.  Applications of carrier erythrocytes in delivery of biopharmaceuticals. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[44]  S. Mitragotri,et al.  Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Xiaofei Wang,et al.  Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy. , 2016, Biomaterials.

[46]  L Bigi,et al.  Erythrocyte‐mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease , 2001, Biotechnology and applied biochemistry.

[47]  Ronnie H. Fang,et al.  Nanoparticles disguised as red blood cells to evade the immune system , 2012, Expert opinion on biological therapy.

[48]  H. Lodish,et al.  Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin , 2017, Nature Communications.

[49]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[50]  QUAN LIU,et al.  Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[51]  R. Sheeladevi,et al.  Detoxification of formate by formate dehydrogenase-loaded erythrocytes and carbicarb in folate-deficient methanol-intoxicated rats. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[52]  Ronnie H. Fang,et al.  Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. , 2013, Nanoscale.

[53]  Liangfang Zhang,et al.  Erythrocyte‐Inspired Delivery Systems , 2012, Advanced healthcare materials.